NCT07009054

Brief Summary

This randomized control trial aims to evaluate the effectiveness of a culturally and linguistically adapted nutrition education and physical exercise program on lifestyle (diet and exercise), metabolic parameters, and fat content and distribution of people of Pakistani origin with obesity residing in the North Metropolitan health area of Barcelona. The betterment of the mentioned parameters is expected to be greater in individuals from the intervention group who will receive a total of 12 sessions of nutrition education and physical exercise compared to the control group who will participate in only 4 sessions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable obesity

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 3, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 29, 2024

Completed
6 months until next milestone

First Posted

Study publicly available on registry

June 6, 2025

Completed
Last Updated

June 6, 2025

Status Verified

May 1, 2025

Enrollment Period

8 months

First QC Date

November 29, 2024

Last Update Submit

May 29, 2025

Conditions

Keywords

obesitymetabolic syndromediet

Outcome Measures

Primary Outcomes (18)

  • Fat mass and total body mass measured by bioimpedance analysis

    Body fat mass and total body mass will be quantified using bioimpedanciometry

    Baseline, 3 months and 6 months

  • Thickness of superficial and pre-peritoneal fat (mm) measured by ultrasound of the rectus abdominis

    Subcutaneous and pre-peritoneal fat thickness will be assessed using ultrasound imaging of the rectus abdominis muscle.

    Baseline, 3 months, and 6 months

  • Quadriceps muscle thickness (mm) measured by ultrasound

    Muscle mass will be evaluated through ultrasound measurements of the quadriceps muscl

    Baseline, 3 months, and 6 months

  • Body Mass Index (BMI) in kg/m²

    BMI will be calculated as weight in kilograms divided by height in meters squared (BMI = kg/m²). Weight will be measured using a calibrated digital scale, and height will be measured with a portable stadiometer.

    Baseline, 3 months, and 6 months

  • Waist circumference (cm)

    Waist circumference will be measured at the midpoint between the lowest rib and the iliac crest using non-stretchable tape, recorded to the nearest 0.1 cm with the participant standing.

    Baseline, 3 months, and 6 months

  • Physical exercise

    The information related to the physical exercise will be gathered through the validated Urdu version of the International Physical Activity Questionnaire (IPAQ). Results will be reported as a continuous variable (MET minutes a week). Furthermore, participants from both the control and the intervention group will be provided with a smartwatch that will register their daily physical activity. The results will be presented in total minutes of intense and moderate physical activity per week.

    Baseline, 3 months and 6 months

  • Health-related quality of life

    Perceived physical and mental health will be assessed using the 12-Item Short Form Survey (SF-12). The SF-12 is a self-reported outcome measure of health-related quality of life, widely used in various ethnic groups. It consists of 12 questions that are scored in various ways. The total score range is 12-47 (higher scores mean a worse outcome).

    Baseline, 3 months and 6 months

  • Fasting glucose level (mg/dL)

    Fasting glucose will be measured in serum samples using enzymatic methods.

    Baseline, 3 months, and 6 months

  • Hemoglobin A1C (%)

    HbA1c will be measured from whole blood using high-performance liquid chromatography (HPLC).

    Baseline, 3 months, and 6 months

  • Insulin (mIU/L)

    Fasting insulin concentration will be measured using electrochemiluminescence immunoassay.

    Baseline, 3 months, and 6 months

  • Aspartate aminotransferase (AST)(UI/L)

    AST will be measured via kinetic UV test using an automated analyzer.

    Baseline, 3 months, 6 months

  • Alanine aminotransferase (ALT)(UI/L)

    ALT will be measured via kinetic UV test using an automated analyzer.

    Baseline, 3 months, 6 months

  • Gamma-glutamyl transferase (GGT)(UI/L)

    GGT will be measured using enzymatic colorimetric methods.

    Baseline, 3 months, 6 months

  • Total cholesterol (mg/dL)

    Total cholesterol will be measured using enzymatic colorimetric methods.

    Baseline, 3 months, 6 months

  • LDL cholesterol (mg/dL)

    LDL-C will be measured directly via homogenous enzymatic assay.

    Baseline, 3 months, 6 months

  • HDL cholesterol (mg/dL)

    HDL-C will be measured directly via homogenous enzymatic assay.

    Baseline, 3 months, 6 months

  • Adherence to Mediterranean Diet using modified MEDAS questionnaire

    Adherence to the Mediterranean Diet will be assessed using a modified version of the 14-item Mediterranean Diet Adherence Screener (MEDAS), excluding the alcohol intake item (13 items total). Scores range from 0 to 13, with higher scores indicating better adherence. A score \< 9 indicates low adherence; ≥ 9 indicates good adherence.. Unit of measure: score 0-13

    Baseline, 3 months, 6 months

  • Nutrient intake measured by 24-hour Dietary Recall

    Nutrient and food group intake will be assessed using a structured 24-hour Dietary Recall (24HR), administered by trained staff. Data will be analyzed using nutritional analysis software to estimate daily intake. Unit of measure: grams, Kcal

    Baseline, 3 months, 6 months

Secondary Outcomes (10)

  • Sociodemographic data

    Baseline

  • Clinical history

    Baseline

  • Toxic habits

    Baseline, 3 months and 6 months

  • Nutrition knowledge

    Baseline, 3 months and 6 months

  • Nutrition skills

    Baseline, 3 months and 6 months

  • +5 more secondary outcomes

Study Arms (2)

Active

ACTIVE COMPARATOR

Life-style interventions (diet and exercise)

Behavioral: Nutrition Education and Exercise

Control

OTHER

Usual care

Behavioral: Usual Care Group

Interventions

A 6-week intensive randomized controlled trial will be conducted with a total of 60 participants. Thirty participants will be assigned to the intervention group and thirty to the control group through simple randomization using a table of random numbers. The intervention group will receive one weekly theoretical-practical nutrition education session in Urdu and one physical activity session based on Nordic walking per week, for a total of six nutrition sessions and six physical activity sessions over the 6-week period.

Active

The control group will participate in 2 theoretical sessions of nutrition education and 2 of physical exercise.

Also known as: Usual care
Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being of Pakistani origin
  • Being Aged over 18 years
  • Having obesity, defined as BMI ≥ 27 Kg/m2
  • Being attended at the Saint Roc or Gorg Primary Care Centers, Endocrinology and Nutrition External Consultations at the Germans Trias i Pujol University Hospital (HUGTiP) or at the Specialized Care Center (Dr. Barraquer in St. Adrià and Dr. Robert in Badalona)
  • Voluntarily accepting participation in the study.

You may not qualify if:

  • Presenting a physical or mental illness that could prevent participation in the study.
  • Presenting any pathology that could limit life expectancy in the short term.
  • Pregnancy.
  • Having a close family member included in the project.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitari Germans Trias i Pujol

Badalona, Barcelona, 08916, Spain

Location

MeSH Terms

Conditions

ObesityMetabolic Syndrome

Interventions

Nutrition AssessmentExercise

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsInsulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationEpidemiologic MeasurementsPublic HealthEnvironment and Public HealthMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Maria-Teresa Julian, MD

    Hospital Universitario Germans Trias i Pujol (Badalona)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 29, 2024

First Posted

June 6, 2025

Study Start

March 3, 2024

Primary Completion

October 30, 2024

Study Completion

October 30, 2024

Last Updated

June 6, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations